Holen Sie sich die Stockscreener-App
2.26
8.10%
-0.21
Adial Pharmaceuticals Inc Aktie (ADIL) Neueste Nachrichten
Adial Pharmaceuticals signs exclusive AD04 collaboration framework with Molteni Farmaceutici for Europe - marketscreener.com
Adial Pharmaceuticals (ADIL) Plans European Expansion for AD04 w - GuruFocus
Adial Pharmaceuticals signs framework deal with Molteni for Europe - Investing.com India
Adial Pharmaceuticals Secures European Partnership for AD04 Commercialization - TipRanks
Adial Pharmaceuticals enters exclusive AD04 Europe framework with Molteni; potential $60M in royalties & milestones - TradingView
Adial (NASDAQ: ADIL) outlines AD04 Europe deal framework with Molteni - Stock Titan
Genetic alcohol use drug AD04 lines up $60M Europe framework - Stock Titan
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
EXCLUSIVE: Adial Pharma Eyes Europe Deal For Lead Drug For Alcohol Use Disrder Worth Up To $60 Million - Bitget
Adial Pharmaceuticals (ADIL) to Release Quarterly Earnings on Tuesday - Defense World
Adial Pharmaceuticals Highlights FDA Policy Direction That May Reduce Pivotal Trial Burden from Two Studies to One - ADVFN Ltd
Adial Pharmaceuticals, IncWarrant (NQ: ADILW - The Chronicle-Journal
Adial Pharmaceuticals Secures Exchange Listing Amid Regulatory Tailwinds - AD HOC NEWS
Short Interest in Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Decreases By 87.7% - Defense World
ADIL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
ARMISTICE CAPITAL, LLC Acquires Shares in Adial Pharmaceuticals Inc - GuruFocus
Key facts: Adial Pharmaceuticals meets Nasdaq bid requirement; advances AD04 to Phase 3 trial - TradingView
Adial Pharmaceuticals Regains Nasdaq Compliance, Advances AD04 Program - TipRanks
Adial Pharmaceuticals Regains Full Compliance with Nasdaq Listing Requirement - Bitget
Adial Pharmaceuticals regains full compliance with Nasdaq listing requirement - marketscreener.com
Adial Regains Nasdaq Compliance as AD04 Advances, Engages in Partnering Talks - TradingView
Adial Pharmaceuticals Regains Full Compliance With Nasdaq Listing Requirement - TradingView
Adial cleared by Nasdaq after 10 days with shares at $1 or more - Stock Titan
Adial Pharmaceuticals eyes single pivotal trial path for AD04 - Investing.com India
Adial Pharmaceuticals eyes single pivotal trial path for AD04 By Investing.com - Investing.com South Africa
Adial Pharmaceuticals stock rises on FDA policy shift - Investing.com
Adial Pharmaceuticals stock rises on FDA policy shift By Investing.com - Investing.com Canada
Adial Pharmaceuticals (ADIL) Sees Potential in FDA's New Approva - GuruFocus
Portfolio Shifts: Can Adial Pharmaceuticals Inc outperform under higher oil pricesJuly 2025 Volume & Consistent Profit Alerts - baoquankhu1.vn
ADIL Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Alcohol Use Disorder Pipeline 2026: Latest FDA Approvals, Clinical Trials, And Emerging Therapies Assessment By Delveinsight Alkermes, Teva Pharma, Biocorrx, Inc., Adial Pharma, ADDEX THERAPEUTICS - Mena FN
Fund Flows: Whats the beta of Adial Pharmaceuticals Inc stockCPI Data & Technical Entry and Exit Alerts - baoquankhu1.vn
Adial Pharmaceuticals to Present at Oppenheimer Conference - Intellectia AI
Adial Pharmaceuticals to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - Bitget
Litchfield Hills Research Estimates ADIL FY2025 Earnings - Defense World
ADIL Technical Analysis & ETF Price Forecast - Intellectia AI
Can Adial Pharmaceuticals Inc. outperform under higher oil pricesEarnings Growth Summary & Low Risk Entry Point Tips - mfd.ru
Buyback Watch: Whats the beta of Adial Pharmaceuticals Inc stockSell Signal & Community Consensus Picks - baoquankhu1.vn
Will Adial Pharmaceuticals Inc. stock benefit from commodity pricesJuly 2025 Chart Watch & High Accuracy Swing Trade Signals - mfd.ru
Will Adial Pharmaceuticals Inc. benefit from geopolitical trends2025 Macro Impact & Growth Focused Entry Point Reports - mfd.ru
Market Leaders: Whats the fair value of Adial Pharmaceuticals Inc stockJuly 2025 Catalysts & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Why did Adial Pharmaceuticals stock plunge over 20% after hours today? - MSN
Why Is Adial Pharmaceuticals Stock (ADIL) Down Today? - TipRanks
Key facts: Adial Pharmaceuticals to execute reverse stock split; supports FDA trial - TradingView
Dow Jumps Over 200 Points; Uber Shares Fall After Q4 Results - Benzinga
Adial Pharmaceuticals Commends Congressional Directive for Alternative Clinical Trial Endpoints in Substance Use Disorder Treatments - Quiver Quantitative
Adial Pharma To Effect 1 For 25 Reverse Stock Split To Regain Nasdaq Compliance; Shares Plunge - Nasdaq
Adial Applauds Congressional Directive Advancing Alternative Clinical Trial Endpoints for Substance Use Disorders, Strengthening Regulatory Path for AD04 - marketscreener.com
Super Micro Computer Q2 Earnings Exceed Expectations - Intellectia AI
Why Super Micro Computer Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Benzinga
Why Did Adial Pharmaceuticals Stock Plunge Over 20% After Hours Today? - Menafn.com
Adial Pharmaceuticals Applauds New Legislation for Addiction Treatment - Intellectia AI
U.S. Stocks Mixed; Eli Lilly Shares Surge After Earnings Beat - Intellectia AI
Adial Pharmaceuticals stock tumbles after announcing 1-for-25 reverse split - Investing.com Nigeria
1.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):